**REGISTERED COMPANY NUMBER: CE017645 (England and Wales) REGISTERED CHARITY NUMBER: 1183632** **Report of the Trustees and Unaudited Financial Statements for the Period 29 May 2019 to 31 October 2020 for Essex Cancer Research** Pugh Clarke & Co Suites 17 & 18 Riverside House Lower Southend Road Wickford Essex SS11 8BB **Essex Cancer Research** **Contents of the Financial Statements for the Period 29 May 2019 to 31 October 2020** **Page Report of the Trustees** 1 to 3 **Statement of Financial Activities** 4 **Balance Sheet** 5 **Notes to the Financial Statements** 6 to 7 **Essex Cancer Research** ## **Report of the Trustees** ## **for the Period 29 May 2019 to 31 October 2020** The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the period 29 May 2019 to 31 October 2020. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). Accounting and Reporting by Charities: Statement of Recommended Practice applicable to accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic The objects of the CIO are to relieve sickness and to preserve and protect good health for the public benefit in Essex by: access to cancer research; 2. Supporting local clinicians to initiate and undertake cancer research; between Academia, Industry and the NHS to create a cancer research hub; and 4. public benefit can be claimed this year. Emphasis of the charity's activities in this first year of the content of the website; holding a fundraising event; establishing contacts with and Anglia Ruskin University; a promotional video was produced; Medical Advisory Board shared with all trustees. We recognise the longer term nature of the charity's development we have benefited from the experience of Oksana Hoile as Chair of the Medical Advisory as hon. Treasurer. We are also grateful to staff at OCL Ltd who have supported other than agreeing to provide awards to top 6 MSc Research in Cancer Biology project ## **INCORPORATION** The charitable company was incorporated on 29 May 2019. ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** The objects of the CIO are to relieve sickness and to preserve and protect good health for the public benefit in Essex by: 1. Widening the access to cancer research; 2. Supporting local clinicians to initiate and undertake cancer research; 3. Promoting collaboration between Academia, Industry and the NHS to create a cancer research hub; and 4. Improving availability and accessibility of cancer information for patients and families. ## **Significant activities** Little of direct public benefit can be claimed this year. Emphasis of the charity's activities in this first year were on beginning development of the content of the website; holding a fundraising event; establishing contacts with Universities of Oxford, Essex and Anglia Ruskin University; a promotional video was produced; Medical Advisory Board was established. ## **Public benefit** Guidance has been shared with all trustees. We recognise the longer term nature of the charity's development will not bring intended benefits immediately. ## **Social investments** None **Grant Making** None ## **Volunteers** Other than the trustees we have benefited from the experience of Oksana Hoile as Chair of the Medical Advisory Board and from Mark Capon as hon. Treasurer. We are also grateful to staff at OCL Ltd who have supported our administrative needs. ## **ACHIEVEMENT AND PERFORMANCE Main Achievements of the charity** None at this stage other than agreeing to provide awards to top 6 MSc Research in Cancer Biology project presentations at University of Essex in summer 2021. ## **Fundraising activities** Fundraising event intended for October cancelled due to pandemic. ## **FINANCIAL REVIEW Financial position** The accounts of ECR Ltd were filed with Companies House for 2019-20. Opening of a charity bank account not completed until end of October- considerable delay due to pandemic affect on banking services. Page 1 **Essex Cancer Research** ## **Report of the Trustees** **for the Period 29 May 2019 to 31 October 2020** ## **FINANCIAL REVIEW** **Financial Review** are the unspent funds of the charity. The charity currently owns no fixed assets, so the cash. The general reserve is therefore the free reserves of the charity- there are no designated 2. To fund unexpected expenditure, e.g. when projects overrun, or unplanned events occur 3. Manage economic or regulatory changes which may have unforeseen financial consequences aim is to build up reserves until such time they can used for viable projects, e.g. web Research Fellowships; Prizes/ awards for MSc Research Projects in Cancer Biology (University of Essex). of general reserve needed by looking forward and considering the risks to our funding Chair briefs; Constitution; Commission publications on role of Trustee etc; previous minutes/agendas made available. The general reserves are the unspent funds of the charity. The charity currently owns no fixed assets, so the general reserve is held in cash. The general reserve is therefore the free reserves of the charity- there are no designated funds. The purpose of the general reserve is: 1. To fund working capital 2. To fund unexpected expenditure, e.g. when projects overrun, or unplanned events occur 3. Manage economic or regulatory changes which may have unforeseen financial consequences Our immediate aim is to build up reserves until such time they can used for viable projects, e.g. web development; Research Fellowships; Prizes/ awards for MSc Research Projects in Cancer Biology (University of Essex). We assess the level of general reserve needed by looking forward and considering the risks to our funding balanced against our expenditure commitments. ## **Reasons For Holding Zero Reserves** Reserves held with ECR Ltd pending transfer to charity account. The Charity's principal sources of funds (including any fundraising): Funds to be transferred from ECR Ltd to ECR charity account. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** **Governing document** CIO 'Foundation Model' Constitution **Charity constitution** CIO ## **Recruitment and appointment of new trustees** Interview by 2 trustees, board appoints **Induction and training of new trustees** Chair briefs; Constitution; Commission publications on role of Trustee etc; previous minutes/agendas made available. **REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number** CE017645 (England and Wales) **Registered Charity number** 1183632 ## **Registered office** Suites 17-18 Riverside House Lower Southend Road Wickford Essex SS11 8BB ## **Trustees** J T Cooper J D Bruce K Madhavan Ms C P O'Driscoll T Arnold ## **Company Secretary** Page 2 **Essex Cancer Research** ## **Report of the Trustees for the Period 29 May 2019 to 31 October 2020** **FUNDS HELD AS CUSTODIAN TRUSTEES ON BEHALF OF OTHERS** None - Approved by order of the board of trustees on 27 August 2021 and signed on its behalf by: Approved by order of the board of trustees on 27 August 2021 and signed on its behalf by: J D Bruce - Trustee Page 3 **Essex Cancer Research** **Statement of Financial Activities for the Period 29 May 2019 to 31 October 2020** **----- Start of picture text -----**
Total
funds
Notes £
NET INCOME -
TOTAL FUNDS CARRIED FORWARD -
APPROVAL COPY
**----- End of picture text -----**
The notes form part of these financial statements Page 4 **Essex Cancer Research** ## **Balance Sheet 31 October 2020** |||Total|| |---|---|---|---| |||funds|| ||Notes|£|| |
**NET CURRENT ASSETS**
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
**NET ASSETS**
**FUNDS**
**TOTAL FUNDS**|
3|**OPY**|**-**
**-**
**-**
**-**| - 3 - is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the - not required the company to obtain an audit of its financial statements for the period - that the charitable company keeps accounting records that comply with Sections 386 and 387 financial statements which give a true and fair view of the state of affairs of the charitable of each financial year and of its surplus or deficit for each financial year in accordance with of Sections 394 and 395 and which otherwise comply with the requirements of the Companies - 2006 relating to financial statements, so far as applicable to the charitable company. statements have been prepared in accordance with the provisions applicable to charitable were approved by the Board of Trustees and authorised for issue on 27 August 2021 and The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 October 2020. The members have not required the company to obtain an audit of its financial statements for the period ended 31 October 2020 in accordance with Section 476 of the Companies Act 2006. The trustees acknowledge their responsibilities for (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and - (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. The financial statements were approved by the Board of Trustees and authorised for issue on 27 August 2021 and were signed on its behalf by: J D Bruce - Trustee The notes form part of these financial statements Page 5 **Essex Cancer Research** ## **Notes to the Financial Statements** ## **for the Period 29 May 2019 to 31 October 2020** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** statements of the charitable company, which is a public benefit entity under FRS 102, have in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Practice applicable to charities preparing their accounts in accordance with the Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic the Companies Act 2006. The financial statements have been prepared under the historical The charity is exempt from corporation tax on its charitable activities. Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. funds can only be used for particular restricted purposes within the objects of the charity. arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. **TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the period ended 31 October 2020. There were no trustees' expenses paid for the period ended 31 October 2020. Net movement At in funds 31.10.20 £ £ **-** Net movement in funds, included in the above are as follows: Incoming Resources resources expended in funds £ £ £ **-** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ## **Taxation** The charity is exempt from corporation tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **2. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the period ended 31 October 2020. ## **Trustees' expenses** There were no trustees' expenses paid for the period ended 31 October 2020. ## **3. MOVEMENT IN FUNDS** |**APPRO**
**TOTAL FUNDS**
Net movement in funds, included in the above are as follows:
Incoming
resources
£
**TOTAL FUNDS**
**-**|
Net
movement
At
in funds
31.10.20
£
£
**-**
**-**
Resources
Movement
expended
in funds
£
£
**-**
**-**| |---|---| Page 6 continued... **Essex Cancer Research** **Notes to the Financial Statements - continued for the Period 29 May 2019 to 31 October 2020** ## **4. RELATED PARTY DISCLOSURES** There were no related party transactions for the period ended 31 October 2020. ## Page 7 ## **Virtual Cabinet Portal Digital Signatures** ## **Digital Signature Verification** You can verify that this is a genuine Virtual Cabinet Document Portal signed document by uploading it to the following secure web page: https://www.virtualcabinetportal.com/VerifySignedDocument ## **Signature Dates and Times** All dates and times shown in the signatures below are expressed in Coordinated Universal Time (UTC), which is generally equivalent to GMT. You can find out more about UTC at the following web page: http://www.virtualcabinetportal.com/WhatIsUTC ## **Signature 1** Signed by John Bruce using authentication code blc0ZkN1LCU2dDNa at IP address 86.134.124.164, on 2021/08/27 15:35:37 Z. John Bruce's e-mail address is: johndbruce@btinternet.com.